Extracorporeal Membrane Oxygenation Machine Market Analysis 2026

Key Drivers of Extracorporeal Membrane Oxygenation Machine

Increase in lung transplantation procedures:

There is a drastic increase in the number of lung transplants due to prevailing diseases like cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. For many years, the adoption of ECMO machines in the lung transplantation process has significantly increased due to an increase in the number of severe lung diseases. In the post-lung transplantation hours, there is the rise of a lung injury called, Primary Graft Dysfunction (PGD). 

Expanding Applications in Transplantation and Post-Operative Support:

ECMO is being utilized more frequently for bridge-to-transplant operations and recovery following cardiac surgery. Its capacity to sustain oxygenation and circulation during high-risk surgical procedures has established it as a standard supportive treatment in numerous advanced healthcare environments.

Key Restraining factor of Extracorporeal Membrane Oxygenation Machine

High cost associated with the ECMO products:

The extracorporeal membrane oxygenation machine therapy is quite expensive. The total costs of the ECMO therapy include the cost of a stay at the hospital, and the cost of additional disposable accessories. ECMO therapy requires highly skilled professionals for the patient care and treatment of lung diseases. These standards of maintaining the quality of patient care and their treatment by skilled physicians add to the cost and it differs upon the amount of time the machine is used. Additionally, the increasing technologies in the ECMO machines can lead to an increase in its cost. Thus, they are not affordable in developing countries, which may indirectly impede the market growth of EMCO machines.

Restricted Access in Low- and Middle-Income Nations:

Although it holds clinical significance, the implementation of ECMO is limited in numerous areas owing to financial, logistical, and infrastructural challenges. Inadequate reimbursement policies and a lack of sufficient critical care infrastructure present considerable obstacles to its extensive use.

Key Trends of Extracorporeal Membrane Oxygenation Machine

Integration of Intelligent Monitoring and Remote Management Technologies:
Modern ECMO devices are integrating digital interfaces, data analysis, and remote connectivity capabilities to improve accuracy and safety. These advancements facilitate the early identification of complications and enhance real-time decision-making by ICU teams.

Portable and Transportable ECMO Systems for Emergency Situations:
The creation of compact, mobile ECMO units is making it possible to utilize them during patient transport and in emergency scenarios. This development promotes quicker initiation of life support outside conventional ICU settings, such as in ambulances or field hospitals.

Impact of the COVID-19 pandemic on the Extracorporeal Membrane Oxygenation Machine (ECMO) Market

The extracorporeal membrane oxygenation machine (ECMO) market was beneficially impacted by the COVID-19 pandemic. ECMO machine was used to treat COVID-19-associated acute respiratory distress syndrome (ARDS)patients. As reported by, Extracorporeal Life Support Organization (ELSO), nearly 3,000 procedures were taken place during the pandemic with confirmed COVID-19 ARDS. Additionally, the developments in ECMO machine technology, like centrifugal pumps, dual lumen cannula, and improved oxygenators, as well as widely improved staff training drove its market growth due to the pandemic. Globally, during the spread of COVID-19, ECMO machines were hugely recognized as a way to increase the survival of patients suffering from cardiac and respiratory diseases. Therefore, an increased number of patients with COVID-19-associated ARDS boosted the growth of the ECMO machine market globally.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Extracorporeal Membrane Oxygenation Machine Market is witnessing significant growth in the near future.

In 2023, the Veno-Venous segment accounted for noticeable share of global Extracorporeal Membrane Oxygenation Machine Market and is projected to experience significant growth in the near future.

The Cardiac application segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Livanova Plc , LivaNova (Alung Technologies Inc.) and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)